The treatment for people with anxiety is now on the cusp of a revolution, and with that, hope has returned for the millions of Americans who have struggled with the problem for many years. This is especially the case since the field has had very few advances over the decades with the medications available for the problem.
Among the emerging treatments that are being closely followed for anxiety is MM120, an LSD-derived molecule that appears to be very effective in Phase 2 studies for generalized anxiety disorder. A dose of MM120 resulted in meaningful anxiety reduction that lasted for weeks, and this paved the way for a Phase 3 trial, potentially offering a novel class of medications for anxiety after almost two decades. Initial studies using psilocybin-assisted therapy also indicate that those with treatment-resistant anxiety can achieve long-lasting improvement.
Parallel with these pharmacological discoveries, the way that people with anxiety can be treated is being revolutionized with Prescription Digital Therapeutic technologies and Artificial Intelligence-assistance platforms. Platforms, for example, like Daylight Rx, an online CBT-anxiety treatment, have reached remission rates of more than 70% with beneficial effects being observed for at least six months. These platforms can assist patients in implementing
Source: Compass Associates – Future Research in Anxiety Treatment, The Online GP – New Anxiety & Depression Treatments 2024–2025
Leave a Comment